Hepcidin and Iron Status in Patients With Inflammatory Bowel Disease Undergoing Induction Therapy With Vedolizumab or Infliximab

BACKGROUND: Hepcidin, the systemic iron regulator, could be critical in differentiating iron deficiency (ID) from functional iron restriction in inflammatory bowel disease (IBD). We assessed hepcidin as a diagnostic ID marker and explored the relationship between hepcidin and its regulators in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Loveikyte, Roberta, Bourgonje, Arno R, van der Reijden, Johannes J, Bulthuis, Marian L C, Hawinkels, Lukas J A C, Visschedijk, Marijn C, Festen, Eleonora A M, van Dullemen, Hendrik M, Weersma, Rinse K, van Goor, Harry, van der Meulen-de Jong, Andrea E, Dijkstra, Gerard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Translational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393210/
https://www.ncbi.nlm.nih.gov/pubmed/36748574
http://dx.doi.org/10.1093/ibd/izad010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393210/
https://www.ncbi.nlm.nih.gov/pubmed/36748574
http://dx.doi.org/10.1093/ibd/izad010

Ejemplares similares